Related references
Note: Only part of the references are listed.Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation
Rajib Shome et al.
CELLULAR ONCOLOGY (2021)
Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β-catenin signaling in gastric cancer subtypes
Divya Bhaskar Rao et al.
DRUG DEVELOPMENT RESEARCH (2021)
Search for Novel Plasma Membrane Proteins as Potential Biomarkers in Human Mesenchymal Stem Cells Derived from Dental Pulp, Adipose Tissue, Bone Marrow, and Hair Follicle
Gurler Akpinar et al.
JOURNAL OF MEMBRANE BIOLOGY (2021)
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Extra-axial skeletal poorly differentiated chordoma: a case report
Petra Balogh et al.
HISTOPATHOLOGY (2020)
Ubiquitin-specific protease 7 downregulation suppresses breast cancer in vitro
Taha Bartu Hayal et al.
TURKISH JOURNAL OF BIOLOGY (2020)
Chordoma: update on disease, epidemiology, biology and medical therapies
Anna Maria Frezza et al.
CURRENT OPINION IN ONCOLOGY (2019)
MTNR1B loss promotes chordoma recurrence by abrogating melatonin-mediated β-catenin signaling repression
Lei Liu et al.
JOURNAL OF PINEAL RESEARCH (2019)
CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling
Hee-Joo Choi et al.
EMBO REPORTS (2019)
Inhibition Of Glycogen Synthase Kinase 3 Beta Suppresses The Growth And Survival Of Skull Base Chordoma Cells By Downregulating Brachyury Expression
Xudong Yan et al.
ONCOTARGETS AND THERAPY (2019)
Small-molecule targeting of brachyury transcription factor addiction in chordoma
Tanaz Sharifnia et al.
NATURE MEDICINE (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury
Paola Magnaghi et al.
MOLECULAR CANCER THERAPEUTICS (2018)
CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma
Juan Duan et al.
EXPERIMENTAL CELL RESEARCH (2018)
Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma
Ryohei Otani et al.
JOURNAL OF NEUROSURGERY (2018)
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study
Gemma Gatta et al.
LANCET ONCOLOGY (2017)
Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer
Sagar R. Shah et al.
CELL REPORTS (2017)
The molecular aspects of chordoma
Sukru Gulluoglu et al.
NEUROSURGICAL REVIEW (2016)
Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer
Shinichiro Shimamatsu et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Pediatric Chordomas: A Population-Based Clinical Outcome Study Involving 86 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011)
Christine S. M. Lau et al.
PEDIATRIC NEUROSURGERY (2016)
Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers
Stefano Radaelli et al.
SPINE (2016)
Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer
Jana Jezkova et al.
ONCOTARGET (2016)
Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
Mukesh K. Pandey et al.
THERANOSTICS (2016)
Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas An Immunohistochemical Study of 5229 Cases
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
Duane H. Hamilton et al.
ONCOTARGET (2015)
Chordoma: an update on the pathophysiology and molecular mechanisms
Xin Sun et al.
CURRENT REVIEWS IN MUSCULOSKELETAL MEDICINE (2015)
Incidence and survival patterns of cranial chordoma in the United States
Kyle J. Chambers et al.
LARYNGOSCOPE (2014)
Incidence and relative survival of chordomas The Standardized Mortality Ratio and the Impact of Chordomas on a Population
Nicolas R. Smoll et al.
CANCER (2013)
Multidisciplinary Management of Recurrent Chordomas
Yoshiya Yamada et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2013)
Tankyrase and the Canonical Wnt Pathway Protect Lung Cancer Cells from EGFR Inhibition
Matias Casas-Selves et al.
CANCER RESEARCH (2012)
Signaling Network Crosstalk in Human Pluripotent Cells: A Smad2/3-Regulated Switch that Controls the Balance between Self-Renewal and Differentiation
Amar M. Singh et al.
CELL STEM CELL (2012)
Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer
Mario Roselli et al.
CLINICAL CANCER RESEARCH (2012)
Current Surgical Outcomes for Cranial Base Chordomas: Cohort Study of 95 Patients
Salvatore Di Maio et al.
NEUROSURGERY (2012)
Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target Laboratory investigation
Wesley Hsu et al.
JOURNAL OF NEUROSURGERY (2011)
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study
Nadege Presneau et al.
JOURNAL OF PATHOLOGY (2011)
Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma
Brian J. Jian et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Baozhi Chen et al.
NATURE CHEMICAL BIOLOGY (2009)
T (brachyury) gene duplication confers major susceptibility to familial chordoma
Xiaohong R. Yang et al.
NATURE GENETICS (2009)
Immunohistochemical Comparison of Chordoma With Chondrosarcoma, Myxopapillary Ependymoma, and Chordoid Meningioma
Hyun-Yee Cho et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
Brachyury expression in extra-axial skeletal and soft tissue chordomas: A marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue
Roberto Tirabosco et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy
Claudia Palena et al.
CLINICAL CANCER RESEARCH (2007)
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Thomas Schlange et al.
BREAST CANCER RESEARCH (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
T-box genes in early embryogenesis
C Showell et al.
DEVELOPMENTAL DYNAMICS (2004)
GSK-3-selective inhibitors derived from Tyrian purple indirubins
L Meijer et al.
CHEMISTRY & BIOLOGY (2003)
Regulation of Wnt signaling during adipogenesis
CN Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Brachyury is a target gene of the Wnt/β-catenin signaling pathway
SJ Arnold et al.
MECHANISMS OF DEVELOPMENT (2000)
Share Paper
